{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:12:36Z","timestamp":1790251956231,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.thromres.2020.06.018","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T21:24:13Z","timestamp":1591737853000},"page":"146-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Effects of platelet and phospholipids on clot formation activated by a small amount of tissue factor"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9021-8633","authenticated-orcid":false,"given":"Hideo","family":"Wada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohshi","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Shimpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motomu","family":"Shimaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2020.06.018_bb0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1055\/s-0039-1692210","article-title":"Clinical application of thromboelastography\/thromboelastometry (TEG\/TEM) in the neonatal population: a narrative review","volume":"45","author":"Konstantinidi","year":"2019","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2020.06.018_bb0010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1373\/clinchem.2015.248625","article-title":"Thrombin generation assay and its application in the clinical laboratory","volume":"62","author":"Tripodi","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.thromres.2020.06.018_bb0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2019.04.019","article-title":"Modulation of the mammalian coagulation system by venoms and other proteins from snakes, arthropods, nematodes and insects","volume":"178","author":"Sachetto","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.06.018_bb0020","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1055\/s-0030-1265295","article-title":"Thrombin generation testing for monitoring hemophilia treatment: a clinical perspective","volume":"36","author":"Salvagno","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2020.06.018_bb0025","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/jth.14487","article-title":"Blood coagulation factor Va\u2019s key interactive residues and regions for prothrombinase assembly and rothrombin binding","volume":"17","author":"Schreuder","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.06.018_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1751-553X.2010.01248.x","article-title":"A study of atypical APTT derivative curves on the ACL TOP coagulation analyser","volume":"33","author":"Solano","year":"2011","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.thromres.2020.06.018_bb0035","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.1111\/hae.13266","article-title":"Clot waveform analysis using CS-2000iTM distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A","volume":"23","author":"Matsumoto","year":"2017","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2020.06.018_bb0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2257.2002.00457.x","article-title":"Waveform analysis of clotting test optical profiles in the diagnosis and management of disseminated intravascular coagulation (DIC)","volume":"24","author":"Toh","year":"2002","journal-title":"Clin. Lab. Haematol."},{"key":"10.1016\/j.thromres.2020.06.018_bb0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/107602960601200206","article-title":"Frequency of abnormal biphasic aPTT clot waveforms in patients with underlying disorders associated with disseminated intravascular coagulation","volume":"12","author":"Matsumoto","year":"2006","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2020.06.018_bb0050","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood.V100.7.2522","article-title":"Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca(++)-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation","volume":"100","author":"Toh","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2020.06.018_bb0055","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1751-553X.2007.00979.x","article-title":"Prognostic implications of a biphasic waveform for APTT analysis in a district general hospital","volume":"30","author":"Mair","year":"2008","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.thromres.2020.06.018_bb0060","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-0037-1613023","article-title":"The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C)","volume":"87","author":"Shima","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.06.018_bb0065","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12185-016-2108-x","article-title":"A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity","volume":"105","author":"Matsumoto","year":"2017","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.thromres.2020.06.018_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157835","article-title":"Exogenous magnesium chloride reduces the activated partial thromboplastin times of lupus anticoagulant-positive patients","volume":"11","author":"Tokutake","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2020.06.018_bb0075","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1177\/1076029617724230","article-title":"An evaluation of the activated partial thromboplastin time waveform","volume":"24","author":"Matsumoto","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2020.06.018_bb0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/ijlh.12727","article-title":"Monitoring of hemostatic abnormalities in major orthopedic surgery patients treated with edoxaban by APTT waveform","volume":"40","author":"Hasegawa","year":"2018","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.thromres.2020.06.018_bb0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12959-019-0201-0","article-title":"Usefulness of the APTT waveform for the diagnosis of DIC and prediction of the outcome or bleeding risk","volume":"17","author":"Suzuki","year":"2019","journal-title":"Thromb. J."},{"key":"10.1016\/j.thromres.2020.06.018_bb0090","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/ijlh.12724","article-title":"Depasse: clot waveform analysis: where do we stand in 2017?","volume":"39","author":"Sevenet","year":"2017","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.thromres.2020.06.018_bb0095","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/jth.14190","article-title":"Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa\/factor X bispecific antibody emicizumab: comment","volume":"16","author":"Matsumoto","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.06.018_bb0100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.thromres.2018.12.016","article-title":"Dynamic evaluation of hemostasis in the acute phase of Kawasaki disease using comprehensive coagulation functional assays","volume":"174","author":"Yoshizawa","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.06.018_bb0105","article-title":"Distinct features of bivalent direct thrombin inhibitors, hirudin and bivalirudin, revealed by clot waveform analysis and enzyme kinetics in coagulation assays","volume":"31","author":"Wakui","year":"2019","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.thromres.2020.06.018_bb0110","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/jth.14022","article-title":"Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa\/factor X bispecific antibody emicizumab","volume":"16","author":"Nogami","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.06.018_bb0115","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/bjh.16111","article-title":"A novel simultaneous clot-fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders","volume":"187","author":"Nogami","year":"2019","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2020.06.018_bb0120","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1177\/1076029618757344","article-title":"An evaluation of hemostatic abnormalities in patients with hemophilia according to the activated partial thromboplastin time waveform","volume":"24","author":"Katayama","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2020.06.018_bb0125","doi-asserted-by":"crossref","DOI":"10.1177\/1076029618824419","article-title":"Comments to: an evaluation of hemostatic abnormalities in patients with hemophilia by APTT waveform, peak heights of APTT waveform are useful for diagnosing hemophilia or inhibitor","volume":"25","author":"Matsumoto","year":"2019","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"377","key":"10.1016\/j.thromres.2020.06.018_bb0130","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1703068","article-title":"Emicizumab prophylaxis in hemophilia A with inhibito","volume":"31","author":"Oldenburg","year":"2017","journal-title":"N. Engl. J. Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820302607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820302607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:42:54Z","timestamp":1758735774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384820302607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":26,"alternative-id":["S0049384820302607"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2020.06.018","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of platelet and phospholipids on clot formation activated by a small amount of tissue factor","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2020.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}